NCRD’s Sterling Institute of Pharmacy : Fees, Admission 2026, Courses, Cutoff, Ranking, Placement

Navi Mumbai, Maharashtra Approved By: AICTEPCI Private Estd: 2004 Gender: Coed
Angel Youth Education TeamContent writer
Updated At : Nov 18, 2026 02:14 PM

NCRD’s Sterling Institute of Pharmacy (NCRDSIP) is a private pharmacy institute affiliated to the University of Mumbai. It is approved by the Pharmacy Council of India (PCI) and AICTE, and operates under the NCRD Trust in Nerul, Navi Mumbai, Maharashtra. The B.Pharm programme at NCRDSIP holds NBA accreditation valid through 2028, making it one of the NBA-accredited pharmacy colleges in the Navi Mumbai region.

NCRDSIP does not currently appear in the NIRF Pharmacy ranked list.

The institute is located in Nerul (East), Navi Mumbai, close to Seawoods-Darave railway station on the Harbour Line, offering convenient commuting access for students from across Mumbai and Navi Mumbai.

  • B.Pharm — 4 years, 100 approved seats (DTE code PH3230), NBA accredited till 2028
  • B.Pharm Lateral Entry — 3 years, open to D.Pharm pass-outs
  • D.Pharm — 2 years
  • M.Pharm — postgraduate programme

The total B.Pharm fee is INR 5,77,300 for the full four-year programme. B.Pharm Lateral Entry costs INR 4,32,000 over three years. D.Pharm total fee is INR 1,76,000 for two years.

Campus placements span pharmaceutical, retail pharmacy, and clinical research sectors. Companies such as Lupin, Cipla, Sandoz, IPCA Laboratories, Apollo Pharmacy, Merck, and Wellness Forever have recruited NCRDSIP students.

Admission Update: NCRDSIP admissions for the 2026-27 academic session are in progress through DTE Maharashtra CAP. B.Pharm CAP allotment rounds have been completed. Candidates who have received allotment letters should complete document verification and fee payment at the institute to confirm admission. D.Pharm admission status can be verified at dtemaharashtra.gov.in.

Address: Plot No. 93,Sector - 19 Nerul(E), Opposite to Seawood Rly.Station, India

0/50 verified reviews
50%
40%
30%
20%
10%

Studied at NCRD's Sterling Institute of Pharmacy Navi Mumbai? Share your experience.

Frequently Asked Questions

Yes. The B.Pharm programme at NCRD’s Sterling Institute of Pharmacy holds NBA accreditation valid through 2028. The programme is also approved by the Pharmacy Council of India and AICTE, and is affiliated to the University of Mumbai.
The total fee for the four-year B.Pharm at NCRDSIP is INR 5,77,300. B.Pharm Lateral Entry over three years costs INR 4,32,000. D.Pharm for two years costs INR 1,76,000.
MHT CET (PCB group) is the primary qualifying exam for B.Pharm at NCRDSIP. Admission is through the DTE Maharashtra Centralised Admission Process (CAP). The DTE code for NCRDSIP B.Pharm is PH3230.
NCRDSIP does not have on-campus hostel facilities. Students typically arrange accommodation in the Nerul or Seawoods areas, which have a large number of paying-guest and rental housing options near the campus.
Based on the 2025-26 cycle, General Category candidates with an MHT CET PCB percentile above 70 were generally competitive for NCRDSIP. The cutoff varies by category and seat availability each year. Check the DTE Maharashtra official merit list for the allotted percentile for the current cycle.
Companies including Lupin, Cipla, Sandoz, IPCA Laboratories, Merck, Apollo Pharmacy, Medlife, Walter Bushnell, and Wellness Forever have recruited NCRDSIP students. Roles are typically in production, quality assurance, quality control, medical representative, and retail pharmacy functions.
Maharashtra state-category candidates must have a valid MHT CET score. All-India (outside Maharashtra) candidates may be considered based on NEET UG or JEE Main PCB stream scores as per DTE Maharashtra rules for the relevant year. There is no direct admission outside the CAP process.
Confused about admission in NCRD's Sterling Institute of Pharmacy Navi Mumbai?Talk to our expert counsellors – it's free.
Chat with us

Get In Touch With Us

By submitting this form you agree that Angel Youth Education may use the details you provide to respond to you, as described in our privacy notice.